Let’s Meet to Discuss Your Next Study

Schedule a meeting to learn more about why biotech sponsors have been choosing PSI CRO for their pivotal Phase 2 and 3 trials for more than 25 years.

Sylvia Demandewicz

Senior Director, Business Development
Mobile: +33 (671) 114 934

Focused & specialized global CRO

Clinical trial sponsors working in oncology, hematology, IBD, infectious diseases, multiple sclerosis, and many rare diseases around the world rely on PSI’s guidance and experience, knowing we’re specialized and committed to delivering some of the most complex clinical projects in the industry.

Read our latest resource

Operationalizing Radiopharmaceutical Clinical Trials: Opportunities & Challenges

Success starts with understanding the risk factors that can impact your radiopharmaceutical trial from startup through the clinical phase.

Discover more about our recent customer success stories and therapeutic experience below
Our mission is to be the best CRO in the world as measured by our employees, clients, investigators, and vendors.
Delivering trials is what we do. It’s our expertise – it’s what we’re dedicated to, and it’s what our teams are built for.
Running oncology studies globally. We plan and execute seamless clinical trials with novel study designs.
PSI is one, if not the only, CRO that has been engaged extensively in gene therapy trials by half a dozen biotech sponsors.
As the need for clinical trials in Crohn’s disease and ulcerative colitis grows, CRO collaboration matters more than ever.
For radiopharmaceutical clinical trials, cooperation and coordination on a global scale is a must.
Consistent delivery on dozens of MS trials, expert knowledge of running placebo-controlled MS trials around the world.
Predictable enrollment and deep connections to sites and staff. PSI is an antibiotic powerhouse.
The challenges of rare disease research, a global approach. Predictability in rare disease clinical trials.